MANHATTAN, NY-AIDS activists from several organizations took over the investor relations office of GlaxoSmithKline Monday, demanding changes in the company's policy of donating drugs to Africa.
People from ACT UP New York, ACT UP Philadelphia, and the Health GAP Coalition worked their way into the office and threw "blood money" and empty pill bottles, while chanting "GlaxoSmithKline! GlobalSerialKiller!" They chained themselves together before there were six arrests.
The major demands of the groups focused on the pharmaceutical giant's lack of initiative to help AIDS patients in sub-Saharan Africa, where more than 35 million people are infected with the virus. Specifically they want: GlaxoSmithKline to drop a lawsuit against the South African government that would allow African officials to obtain inexpensive AIDS drugs to treat its citizens; the pharmaceutical giant to drop any legal action against Cipla Pharmaceuticals, an Indian company that provides generic forms of Glaxo's drugs to African countries; and more drug discounts to African countries.
The activists say more than one million people are dying of AIDS around the world every four months.
Information from www.hivandhepatitis.com
Reflecting on the US Withdrawal from the World Health Organization
January 21st 2025An infection preventionist reels from the US exit from WHO, writing that it disrupts global health efforts, weakens infection control, and lacks research funding and support for low-income nations dependent on WHO for health care resources.
Infections Do Not Recognize International Borders: The Potential Impact of US Withdrawal From WHO
January 21st 2025The US withdrawal from WHO jeopardizes infection prevention, research funding, and global collaboration, disproportionately impacting low-income nations reliant on WHO support for equitable health care advancements.
Infection Intel:EvaClean Expands Global Reach With Microsplitting Partnership
January 20th 2025EvaClean partners with Microsplitting Ltd. to distribute its advanced disinfection systems and absorbents, revolutionizing infection prevention across health care, education, hospitality, and industrial sectors worldwide.